SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001559053-21-000027
Filing Date
2021-07-12
Accepted
2021-07-12 08:57:37
Documents
15
Period of Report
2021-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K prta-20210708.htm   iXBRL 8-K 49231
2 EX-99.1 exhibit991projectpegasusan.htm EX-99.1 19351
6 GRAPHIC image_0.jpg GRAPHIC 120211
7 GRAPHIC image_1.jpg GRAPHIC 6226
  Complete submission text file 0001559053-21-000027.txt   398412

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20210708.xsd EX-101.SCH 1927
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20210708_lab.xml EX-101.LAB 25800
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20210708_pre.xml EX-101.PRE 13686
8 EXTRACTED XBRL INSTANCE DOCUMENT prta-20210708_htm.xml XML 12278
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 211084552
SIC: 2834 Pharmaceutical Preparations